does semaglutide cause low iron Anemia: A Lesser-Known Side Effect of GLP-1 Drugs? Can anemia cause irregular periods

Others prepay for a monthly subscription and skip check-ins because theres no immediate financial penalty

Convenience Topical products fit easily into a daily routine

Morales, E

Key Points The incretins glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are gut-derived hormones that potentiate insulin secretion and contribute to glucose metabolism through a wide range of physiological actions Inhibitors of the incretin-inactivating enzyme dipeptidyl peptidase 4 (DPP-4) and DPP-4-resistant injectable GLP-1 receptor agonists have been developed for the treatment of hyperglycaemia in type 2 diabetes mellitus (T2DM) GLP-1 and other gut-derived hormones might directly and/or indirectly regulate electrolyte and fluid homeostasis by influencing feeding and drinking behaviour as well as electrolyte transport in the kidneys and gastrointestinal tract GLP-1 receptor (GLP-1R) agonists and DPP-4 inhibitors increase natriuresis in T2DM, possibly through overlapping and distinct mechanisms, and might slightly improve renal haemodynamics in the setting of diabetes-related glomerular hyperfiltration Incretin-based therapies seem to directly influence renal physiology and have indirect metabolic and haemodynamic actions that might reduce renal risk in T2DM

Before the discovery of ghrelin receptors, these were actually termed growth hormone secretagogue 1a receptors (GHS-R1a), and the molecules that might interact with them, like GHRP-6, are suggested to be growth hormone secretagogues (GHSs)